COVID-19住院患者中SARS-CoV-2与其他病原体所致脓毒症的患病率、临床特征与结局
该研究为马萨诸塞州四家医院200例随机选取的COVID-19住院患者的横断面回顾性病历审查(2020年3月至2021年3月),按Sepsis-3标准判定脓毒症。200例中65例(32.5%)发生脓毒症,其中46/65(70.8%)仅由SARS-CoV-2引起,17/65(26.2%)由SARS-CoV-2与非SARS-CoV-2感染共同引起,2/65(3.1%)仅由细菌感染引起。SARS-CoV-2相关器官功能障碍中位发生于入院后1天(IQR 0-2天),以呼吸(93.7%)、神经(46.0%)和/或肾脏(39.7%)功能障碍最常见。院内死亡28/200(14.0%),无脓毒症者2/135(1.5%),单纯SARS-CoV-2脓毒症16/46(34.8%),SARS-CoV-2与细菌混合脓毒症10/17(58.8%)。
要点
- COVID-19住院患者脓毒症发生率为32.5%(65/200),其中70.8%(46/65)仅由SARS-CoV-2引起。
- SARS-CoV-2相关器官功能障碍中位发生于入院后1天(IQR 0-2天),呼吸功能障碍占93.7%、神经46.0%、肾脏39.7%。
- 混合SARS-CoV-2与细菌脓毒症患者院内病死率58.8%(10/17),高于单纯SARS-CoV-2脓毒症的34.8%(16/46)。
- 无脓毒症的COVID-19住院患者院内病死率仅1.5%(2/135),总体院内病死率14.0%(28/200)。
- 细菌感染参与了26.2%(17/65)的脓毒症病例,需同时关注病毒与细菌脓毒症的监测、识别、预防和治疗。
适用人群与场景
- 2020年3月至2021年3月在马萨诸塞州四家医院住院的COVID-19患者,随机选取200例进行回顾性病历审查。
诊断标准与关键阈值
- 脓毒症按Sepsis-3标准判定:感染导致序贯器官衰竭评估(SOFA)评分较基线升高≥2分。
- 脓毒症病因分为仅SARS-CoV-2、其他病原体、或两者兼有。
红旗征与不能漏的情况
- SARS-CoV-2相关器官功能障碍中位发生于入院后1天(IQR 0-2天),以呼吸(93.7%)、神经(46.0%)和/或肾脏(39.7%)功能障碍最常见。
- 混合SARS-CoV-2与细菌脓毒症患者院内病死率达58.8%(10/17),高于单纯SARS-CoV-2脓毒症的34.8%(16/46)。
研究设计与关键结果
- 研究类型:横断面回顾性病历审查;样本量200例;四家医院;人群为COVID-19住院患者。
- 脓毒症发生率32.5%(65/200);其中仅SARS-CoV-2 70.8%(46/65),SARS-CoV-2与非SARS-CoV-2感染共同引起26.2%(17/65),仅细菌感染3.1%(2/65)。
- 院内死亡28/200(14.0%):无脓毒症者2/135(1.5%),单纯SARS-CoV-2脓毒症16/46(34.8%),SARS-CoV-2与细菌混合脓毒症10/17(58.8%)。
证据类型、等级与局限
- 证据类型:横断面回顾性病历审查;局限:原文未报告局限性。
对床旁实践的改变
- 作者认为这些发现确认SARS-CoV-2是脓毒症的重要病因,并强调需要改善COVID-19住院患者病毒性与细菌性脓毒症的监测、识别、预防和治疗。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: The prevalence and causes of sepsis in patients hospitalized with COVID-19 are poorly characterized.
OBJECTIVES: To investigate the prevalence, clinical characteristics, and outcomes of sepsis caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) versus other pathogens in patients hospitalized with COVID-19.
DESIGN SETTING AND PARTICIPANTS: Cross-sectional, retrospective chart review of 200 randomly selected patients hospitalized with COVID-19 at four Massachusetts hospitals between March 2020 and March 2021.
MAIN OUTCOMES AND MEASURES: The presence or absence of sepsis was determined per Sepsis-3 criteria (infection leading to an increase in Sequential Organ Failure Assessment score by ≥ 2 points above baseline). Sepsis episodes were assessed as caused by SARS-CoV-2, other pathogens, or both. Rates of organ dysfunction and in-hospital death were also assessed.
RESULTS: Sepsis was present in 65 of 200 COVID-19 hospitalizations (32.5%), of which 46 of 65 sepsis episodes (70.8%) were due to SARS-CoV-2 alone, 17 of 65 (26.2%) were due to both SARS-CoV-2 and non-SARS-CoV-2 infections, and two of 65 (3.1%) were due to bacterial infection alone. SARS-CoV-2-related organ dysfunction in patients with sepsis occurred a median of 1 day after admission (interquartile range, 0-2 d) and most often presented as respiratory (93.7%), neurologic (46.0%), and/or renal (39.7%) dysfunctions. In-hospital death occurred in 28 of 200 COVID-19 hospitalizations (14.0%), including two of 135 patients without sepsis (1.5%), 16 of 46 patients with sepsis (34.8%) due to SARS-CoV-2 alone, and 10 of 17 patients with sepsis (58.8%) due to both SARS-CoV-2 and bacterial pathogens.
CONCLUSIONS: Sepsis occurred in one in three patients hospitalized with COVID-19 and was primarily caused by SARS-CoV-2 itself, although bacterial infection also contributed in a quarter of sepsis cases. Mortality in COVID-19 patients with sepsis was high, especially in patients with mixed SARS-CoV-2 and bacterial sepsis. These findings affirm SARS-CoV-2 as an important cause of sepsis and highlight the need to improve surveillance, recognition, prevention, and treatment of both viral and bacterial sepsis in hospitalized patients with COVID-19.
参考来源
- Shappell CN, Klompas M, Kanjilal S, et al. Prevalence, Clinical Characteristics, and Outcomes of Sepsis Caused by Severe Acute Respiratory Syndrome Coronavirus 2 Versus Other Pathogens in Hospitalized Patients With COVID-19. Crit Care Explor. 2022. PMID: 35783550. doi:10.1097/CCE.0000000000000703
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。